Clincosm LogoSign in Get a demo

MDS

Showing NaN - NaN of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • Orca-T
  • Standard-of-Care
  • Duarte, California
  • +13 more
Jan 25, 2023

Acute Leukemia, MDS Trial in Chicago (device, drug, other)

Recruiting
  • Acute Leukemia
  • MDS
  • Arm1
  • Arm 1
  • Chicago, Illinois
    University of Illinois Cancer Center
Oct 13, 2022

Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or

Terminated
  • Myelodysplastic Syndrome
  • +3 more
  • La Jolla, California
  • +157 more
Sep 22, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Relapsed/Refractory AML, AML, Adult, MDS Trial in United States (NKX101 - CAR NK cell therapy)

Recruiting
  • Relapsed/Refractory AML
  • +3 more
  • NKX101 - CAR NK cell therapy
  • Denver, Colorado
  • +6 more
Apr 8, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727

Completed
Has Results
  • Myelodysplastic Syndrome
  • MDS
  • ASTX727 Dose Escalation
  • +2 more
  • Phoenix, Arizona
  • +16 more
Dec 1, 2020

MDS Trial in Chicago (Lenalidomide and azacitidine combination)

Terminated
Has Results
  • MDS
  • Lenalidomide and azacitidine combination
  • Chicago, Illinois
    Rush University Medical Center
Nov 2, 2020

MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • ON 01910.Na
  • Scottsdale, Arizona
  • +86 more
Jun 29, 2020

Leukemia, Lymphoma, MDS Trial in Chicago (Conditioning Regimen & GVHD Prophylaxis)

Withdrawn
  • Leukemia
  • +2 more
  • Conditioning Regimen & GVHD Prophylaxis
  • Chicago, Illinois
    Ann & Robert H. Lurie Children's Hospital of Chicago
Aug 28, 2019

Myelodysplastic Syndrome, MDS Trial in United States (pracinostat, Azacitidine, Decitabine)

Completed
  • Myelodysplastic Syndrome
  • MDS
  • Mobile, Alabama
  • +20 more
Feb 22, 2017

AML, ALL, Blast Crisis Trial in United States (TG02 citrate, Carfilzomib, Dexamethasone)

Completed
  • AML
  • +4 more
  • TG02 citrate
  • +2 more
  • Denver, Colorado
  • +8 more
May 5, 2016